Related references
Note: Only part of the references are listed.The off-target effects of nonspecific NK cells
Dean A. Lee
BLOOD (2015)
Umbilical cord blood-derived cellular products for cancer immunotherapy
Jeannette Cany et al.
CYTOTHERAPY (2015)
Challenges of cancer therapy with natural killer cells
Hans Klingemann
CYTOTHERAPY (2015)
Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy
Markus Granzin et al.
CYTOTHERAPY (2015)
Ex Vivo-expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients
Susann Szmania et al.
JOURNAL OF IMMUNOTHERAPY (2015)
Advantages and applications of CAR-expressing natural killer cells
Wolfgang Glienke et al.
FRONTIERS IN PHARMACOLOGY (2015)
Combined IL-15 and IL-12 drives the generation of CD34+-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transfer
Jeannette Cany et al.
ONCOIMMUNOLOGY (2015)
Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation
Nirali N. Shah et al.
BLOOD (2015)
Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial
Panagiotis D. Kottaridis et al.
PLOS ONE (2015)
Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor
Kurt Schönfeld et al.
MOLECULAR THERAPY (2014)
Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation
Shiguo Zhu et al.
BLOOD (2014)
NK Cell Genotype and Phenotype at Diagnosis of Acute Lymphoblastic Leukemia Correlate with Postinduction Residual Disease
Erin M. Sullivan et al.
CLINICAL CANCER RESEARCH (2014)
Infusions of Allogeneic Natural Killer Cells as Cancer Therapy
Wing Leung
CLINICAL CANCER RESEARCH (2014)
Tracing dynamic expansion of human NK-cell subsets by high-resolution analysis of KIR repertoires and cellular differentiation
Vivien Beziat et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT)
Bree Foley et al.
IMMUNOLOGICAL REVIEWS (2014)
Immunotherapy in acute myeloid leukemia
Mario Arpinati et al.
IMMUNOTHERAPY (2014)
Donor Killer Cell Ig-like Receptor B Haplotypes, Recipient HLA-C1, and HLA-C Mismatch Enhance the Clinical Benefit of Unrelated Transplantation for Acute Myelogenous Leukemia
Sarah Cooley et al.
JOURNAL OF IMMUNOLOGY (2014)
Improving the outcome of leukemia by natural killer cell-based immunotherapeutic strategies
Salem Chouaib et al.
FRONTIERS IN IMMUNOLOGY (2014)
Are natural killer cells superior CAR drivers?
Hans Klingemann
ONCOIMMUNOLOGY (2014)
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
M. Stern et al.
BONE MARROW TRANSPLANTATION (2013)
Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16 x 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
Andres Wiernik et al.
CLINICAL CANCER RESEARCH (2013)
Accreditation of flow cytometry in Europe
Ulrich Sack et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2013)
Treatment of patients with advanced cancer with the natural killer cell line NK-92
Torsten Tonn et al.
CYTOTHERAPY (2013)
Cellular therapy of cancer with natural killer cells-where do we stand?
Hans G. Klingemann
CYTOTHERAPY (2013)
Effect of Donor KIR2DL1 Allelic Polymorphism on the Outcome of Pediatric Allogeneic Hematopoietic Stem-Cell Transplantation
Rafijul Bari et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo
Okjae Lim et al.
PLOS ONE (2013)
Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity
Nina Shah et al.
PLOS ONE (2013)
Successful in-flight activation of natural killer cells during long-distance shipping
Scott A. Koepsell et al.
TRANSFUSION (2013)
Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions
Hans Klingemann et al.
TRANSFUSION (2013)
Therapeutic applications: natural killer cells in the clinic
Jeffrey S. Miller
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2013)
Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells
Franco Locatelli et al.
FRONTIERS IN IMMUNOLOGY (2013)
Tumor-primed NK cells: waiting for the green light
May Sabry et al.
FRONTIERS IN IMMUNOLOGY (2013)
New prospects on the NKG2D/NKG2DL system for oncology
Evelyn Ullrich et al.
ONCOIMMUNOLOGY (2013)
Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol
Ulrike Koehl et al.
FRONTIERS IN ONCOLOGY (2013)
Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
Natalia Lapteva et al.
CYTOTHERAPY (2012)
NK cells engineered to express a GD2-specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin
Ruth Esser et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors
Jing Ni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Expansion of NK cells from cord blood with antileukemic activity using GMP-compliant substances without feeder cells
J. Tanaka et al.
LEUKEMIA (2012)
Targeting PD-1/PD-L1 interactions for cancer immunotherapy
Laurence Zitvogel et al.
ONCOIMMUNOLOGY (2012)
Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells
Eirini Katodritou et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
Antonio Curti et al.
BLOOD (2011)
Use of NK cell activity in cure by transplant
Wing Leung
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression
Maria R. Parkhurst et al.
CLINICAL CANCER RESEARCH (2011)
Ex vivo expansion of natural killer cells: a question of function
Tolga Sutlu et al.
CYTOTHERAPY (2011)
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
Melissa A. Geller et al.
CYTOTHERAPY (2011)
Leukemic Priming of Resting NK Cells Is Killer Ig-like Receptor Independent but Requires CD15-Mediated CD2 Ligation and Natural Cytotoxicity Receptors
May Sabry et al.
JOURNAL OF IMMUNOLOGY (2011)
IL-2 Stimulated but Not Unstimulated NK Cells Induce Selective Disappearance of Peripheral Blood Cells: Concomitant Results to a Phase I/II Study
Claudia Brehm et al.
PLOS ONE (2011)
Bortezomib Treatment to Potentiate the Anti-tumor Immunity of Ex-vivo Expanded Adoptively Infused Autologous Natural Killer Cells
Andreas Lundqvist et al.
JOURNAL OF CANCER (2011)
Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
Sarah Cooley et al.
BLOOD (2010)
Generation of donor natural killer cells from CD34(+) progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study
S. R. Yoon et al.
BONE MARROW TRANSPLANTATION (2010)
Allogeneic natural killer cells for refractory lymphoma
Veronika Bachanova et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
Eleni G. Iliopoulou et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients
Uwe Siegler et al.
CYTOTHERAPY (2010)
Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor
Tolga Sutlu et al.
CYTOTHERAPY (2010)
IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA
Stephan Kloess et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
Jeffrey E. Rubnitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
IL-2-driven Regulation of NK Cell Receptors With Regard to the Distribution of CD16+ and CD16- Subpopulations and In Vivo Influence After Haploidentical NK Cell Infusion
Sabine Huenecke et al.
JOURNAL OF IMMUNOTHERAPY (2010)
High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy
Jan Spanholtz et al.
PLOS ONE (2010)
Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine245
Rafijul Bari et al.
BLOOD (2009)
Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
Hiroyuki Fujisaki et al.
CANCER RESEARCH (2009)
Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells
Maria Berg et al.
CYTOTHERAPY (2009)
Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study
L. Barkholt et al.
IMMUNOTHERAPY (2009)
Cytokine-induced memory-like natural killer cells
Megan A. Cooper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Clinical-grade purification of natural killer cells in haploidentical hematopoietic stem cell transplantation
Sandrine Meyer-Monard et al.
TRANSFUSION (2009)
Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components
Evren Alici et al.
BLOOD (2008)
Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
S. Arai et al.
CYTOTHERAPY (2008)
A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells
Stephan Kloeb et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer
Shinichiro Motohashi et al.
CLINICAL CANCER RESEARCH (2006)
The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells
Lars Fischer et al.
EXPERIMENTAL HEMATOLOGY (2006)
Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors
W Leung et al.
JOURNAL OF IMMUNOLOGY (2005)
CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets
O Penack et al.
LEUKEMIA (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
A novel four-colour flow cytometric assay to determine natural killer cell or T-cell-mediated cellular cytotoxicity against leukaemic cells in peripheral or bone marrow specimens containing greater than 20% of normal cells
SY Zimmermann et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation
JR Passweg et al.
LEUKEMIA (2004)
Determinants of antileukemia effects of allogeneic NK cells
W Leung et al.
JOURNAL OF IMMUNOLOGY (2004)
IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation
U Koehl et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells:: a clinical phase I trial
SW Krause et al.
CLINICAL CANCER RESEARCH (2004)
Ex vivo expansion of natural killer cells for clinical applications
HG Klingemann et al.
CYTOTHERAPY (2004)
Purification of human natural killer cells using a clinical-scale immunomagnetic method
R Iyengar et al.
CYTOTHERAPY (2003)
Ex vivo expansion of the highly cytotoxic human natural killer cell line NK-92 under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy
YK Tam et al.
CYTOTHERAPY (2003)
Large-scale generation of natural killer lymphocytes for clinical application
J Luhm et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
G Cartron et al.
BLOOD (2002)
Share Paper
